0001609251-24-000002.txt : 20240214 0001609251-24-000002.hdr.sgml : 20240214 20240214161226 ACCESSION NUMBER: 0001609251-24-000002 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240214 DATE AS OF CHANGE: 20240214 EFFECTIVENESS DATE: 20240214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Krensavage Asset Management, LLC CENTRAL INDEX KEY: 0001609251 ORGANIZATION NAME: IRS NUMBER: 262520930 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16807 FILM NUMBER: 24638234 BUSINESS ADDRESS: STREET 1: 610 FIFTH AVENUE STREET 2: SUITE 301 CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: 212-888-1582 MAIL ADDRESS: STREET 1: 610 FIFTH AVENUE STREET 2: SUITE 301 CITY: NEW YORK STATE: NY ZIP: 10020 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE false false false 0001609251 XXXXXXXX 12-31-2023 12-31-2023 Krensavage Asset Management, LLC

610 FIFTH AVENUE SUITE 301 NEW YORK NY 10020

13F HOLDINGS REPORT 028-16807 N Paul J. Paolino 212-518-3193 /s/ Paul J. Paolino New York NY 02-14-2024 0 12 281853 false INFORMATION TABLE 2 krensavage13F12312023.xml KRENSAVAGE ASSET MGT 13F 12.31.2023 ALKERMES PLC COM G01767105 25466 918038 SH SOLE 918038 0 0 BIOGEN INC COM 09062X103 41527 160480 SH SOLE 160480 0 0 CARDINAL HEALTH INC COM 14149Y108 28373 281476 SH SOLE 281476 0 0 ENANTA PHARMACEUTICALS INC COM 29251M106 6990 742824 SH SOLE 742824 0 0 EXELIXIS INC COM 30161Q104 45559 1899079 SH SOLE 1899079 0 0 JAZZ PHARMACEUTICALS PLC COM G50871105 12300 100000 SH SOLE 100000 0 0 MASIMO CORP COM 574795100 938 8000 SH SOLE 8000 0 0 MURAL ONCOLOGY PLC COM G63365103 538 90833 SH SOLE 90833 0 0 REGENERON PHARMACEUTICALS COM 75886F107 41504 47256 SH SOLE 47256 0 0 SANOFI-ADR COM 80105N105 7479 150400 SH SOLE 150400 0 0 TARO PHARMACEUTICAL INDUS COM M8737E108 27009 646453 SH SOLE 646453 0 0 UNITED THERAPEUTICS CORP COM 91307C102 44170 200872 SH SOLE 200872 0 0